Details:

Alternative Title:
Emerg Infect Dis
Personal Author:
Kamboj, Mini ; Brite, Jennifer ; Aslam, Anoshe ; Kennington, Jessica ; Babady, N. Esther ; ... More +
Kamboj, Mini ; Brite, Jennifer ; Aslam, Anoshe ; Kennington, Jessica ; Babady, N. Esther ; Calfee, David ; Furuya, Yoko ; Chen, Donald ; Augenbraun, Michael ; Ostrowsky, Belinda ; Patel, Gopi ; Mircescu, Monica ; Kak, Vivek ; Tuma, Roman ; Karre, Teresa A. ; Fry, Deborah A. ; Duhaney, Yola P. ; Moyer, Amber ; Mitchell, Denise ; Cantu, Sherry ; Hsieh, Candace ; Warren, Nancy ; Martin, Stacy ; Willson, Jill ; Dickman, Jeanne ; Knight, Julie ; Delahanty, Kim ; Flood, Annemarie ; Harrington, Jennifer ; Korenstein, Deborah ; Eagan, Janet ; Sepkowitz, Kent Less -
Description:
In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectively. Higher testing rates may artificially inflate reported rates of C. difficile infection. C. difficile surveillance should consider testing frequency.
Subjects:
[+]
Bacteriological Techniques Clostridium Difficile/genetics Clostridium Infections/diagnosis Clostridium Infections/epidemiology Clostridium Infections/microbiology Dispatch Health Status Disparities Hospitalization Hospitals Humans Nucleic Acid Amplification Techniques Public Health Surveillance
Source:
Emerg Infect Dis. 24(3):584-587.
Pubmed ID:
29460760
Pubmed Central ID:
PMC5823336
Document Type:
Journal Article
Place as Subject:
United States
Location:
North America
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:a8ff3364f506311ba936f1d1c1bb801859d149f4bbb3043f37fedc5f6d8f370d
Download URL:
https://stacks.cdc.gov/view/cdc/52185/cdc_52185_DS1.pdf
File Type:

Supporting Files

• 	17-0961-F1.gif	gif
  	17-0961-F1.jpg	jpeg
  	17-0961-F2.gif	gif
  	17-0961-F2.jpg	jpeg
  	17-0961.nxml	xml

More +